Ireland's Third Fastest Growing Technology Company to Announce up to 100 New Jobs at Opening of New Limerick Office

LIMERICK, Ireland, March 4, 2022 – kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”), Limerick-based software company, Kneat, will announce today the creation of up to 100 new jobs during the opening of its new 13,000 sq. ft green sustainable LEED GOLD standard office at Hawthorn House in Limerick’s National Technology Park.

The new positions will be focused on Sales & Marketing, Research & Development, and Customer Success, bringing its total number of staff to over 300.

The company, which develops cloud-based software solutions for the Life Sciences industry, counts seven of the world’s top ten biopharmaceutical companies as customers. Founded in Limerick in 2007 by pharmaceutical and IT industry experts Eddie Ryan, Kevin Fitzgerald and Brian Ahearne, the company has seen record growth in recent years.

In a ceremony attended by Irish Taoiseach, Micheál Martin, and Enterprise Ireland CEO, Leo Clancy, the company’s new 13,000 sq. ft. office at Hawthorn House will be declared ‘open for business’ by Kneat Co-Founder and CEO Eddie Ryan.

“As a Limerick man I have a deep connection to the people and the city of Limerick, which is why I’m very happy to share the news today that Kneat is announcing up to one-hundred new jobs to be filled over the coming year”, said Eddie Ryan. “We are also very pleased to declare our new office at Hawthorn House, open for business.”

Today’s jobs and new facility announcement are the latest in a list of milestones for the growing business, which ranked third in the Deloitte Technology Fast 50 Ireland Awards in December 2021. In November, the company up listed from the Toronto Venture Exchange (TSXV) to the Toronto Stock Exchange (TSX) and closed a Public Equity Financing of over 20 million Canadian dollars earlier in the year.

About Kneat

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx SaaS platform. Multiple business work processes can be configured on the platform from equipment to computer system validation, through to quality document management. Kneat’s software allows users to author, review, approve, execute testing online, manage any exceptions, and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information, includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the use and implementation timelines of Kneat’s software within the customer’s validation processes, the ability and intent of the customer to scale the use of Kneat’s software within the customer’s organization and the compliance of Kneat’s platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.

The forward-looking information in this press release does not include a full assessment or reflection of the unprecedented impacts of the COVID-19 pandemic occurring since the first quarter of 2020 and the ongoing and developing resulting indirect global and regional economic impacts. This has resulted in significant economic uncertainty and even though the Company has to date experienced no significant impact to its operations, any potential impact on our future is difficult to understand or measure at this time.

Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investors’ own risk.